Literature DB >> 1531747

Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?

R Lahesmaa1, E Eerola, A Toivanen.   

Abstract

Erythrocyte C3b receptor (CR1) activity was measured in 27 patients with yersinia triggered reactive arthritis and in 151 control subjects, including 36 patients with uncomplicated yersiniosis and 115 healthy subjects. CR1 was measured by the immune adherence haemagglutination method. Patients with yersinia triggered reactive arthritis had reduced levels of CR1 compared with the controls. This difference was mainly due to the finding that five out of six HLA B27 negative patients with arthritis had decreased CR1 activity. Such a quantitative difference may contribute to the pathogenesis of reactive arthritis by affecting the clearance of immune complexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531747      PMCID: PMC1004628          DOI: 10.1136/ard.51.1.97

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.

Authors:  B S Thomsen; P Oxholm; R Manthorpe; H Nielsen
Journal:  Arthritis Rheum       Date:  1986-07

2.  Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27.

Authors:  B S Thomsen; S E Jacobsen; H Nielsen; B K Jakobsen; H Sørensen
Journal:  Complement       Date:  1986

3.  Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.

Authors:  J G Wilson; W W Wong; P H Schur; D T Fearon
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

4.  Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.

Authors:  J H Cohen; V Caudwell; M Levi-Strauss; P Bourgeois; M D Kazatchkine
Journal:  Arthritis Rheum       Date:  1989-04

5.  Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.

Authors:  Y Miyakawa; A Yamada; K Kosaka; F Tsuda; E Kosugi; M Mayumi
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

6.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

7.  Clinical correlates of circulating immune complexes in patients with recent yersiniosis.

Authors:  R Kekomäki; K Granfors; R Leino; K Penttinen; P L Lindström; O Wager
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

8.  Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.

Authors:  F Moldenhauer; J David; A H Fielder; P J Lachmann; M J Walport
Journal:  Arthritis Rheum       Date:  1987-09

9.  Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

10.  Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes.

Authors:  J G Wilson; E E Murphy; W W Wong; L B Klickstein; J H Weis; D T Fearon
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  1 in total

1.  Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis.

Authors:  Cristi L Galindo; Jason A Rosenzweig; Michelle L Kirtley; Ashok K Chopra
Journal:  J Pathog       Date:  2011-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.